The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Celgene; Lilly; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Atara Biotherapeutics (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Cellceutix (Inst); Celldex (Inst); Enzychem Lifesciences (Inst); Exelixis (Inst); Gliknik (Inst); Innate Pharma (Inst); Kura Oncology (Inst); Lilly (Inst); Matrix Biomed (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Polaris (Inst)
Travel, Accommodations, Expenses - Pfizer
Tabelecleucel in combination with pembrolizumab (Pembro) in platinum-pretreated, recurrent/metastatic Epstein-Barr virus (EBV)-positive nasopharyngeal carcinoma (EBV+NPC).
 
Lillian L. Siu
Leadership - Agios (I)
Stock and Other Ownership Interests - Agios (I)
Consulting or Advisory Role - AstraZeneca/MedImmune; Loxo; Merck; MorphoSys; Roche; Symphony Evolution
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Symphony Evolution (Inst)
 
Joshua Bauml
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech; Guardant Health; Merck; Takeda
Research Funding - AstraZeneca (Inst); Bayer (Inst); Carevive Systems (Inst); Incyte (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Takeda (Inst)
 
Douglas Adkins
No Relationships to Disclose
 
A. Dimitrios Colevas
Stock and Other Ownership Interests - Gilead Sciences; Pharmacyclics
Consulting or Advisory Role - Aduro Biotech; ATARA Biotherapeutics; COTA; CUE Biopharma; KeyQuest Health; Loxo; Pfizer
Research Funding - AstraZeneca; Bristol-Myers Squibb; Cellsight Technologies; Innate Pharma; Tessa Therapeutics
 
Cesar Augusto Perez
No Relationships to Disclose
 
Jennifer Hsing Choe
No Relationships to Disclose
 
Yang Zhang
Employment - Atara Biotherapeutics
Stock and Other Ownership Interests - Atara Biotherapeutics
 
Wen Shi
Employment - Atara Biotherapeutics
Stock and Other Ownership Interests - Atara Biotherapeutics
 
Willis H. Navarro
Employment - Atara Biotherapeutics
Stock and Other Ownership Interests - Atara Biotherapeutics; GE Healthcare; Kite, a Gilead company; Pfizer
Patents, Royalties, Other Intellectual Property - Patent pending for a use of cytotoxic T lymphocytes (Inst)
 
Missak Haigentz
Stock and Other Ownership Interests - Roche
Consulting or Advisory Role - AstraZeneca; Takeda
 
Guilherme Rabinowits
Stock and Other Ownership Interests - Regeneron; Syros Pharmaceuticals
Consulting or Advisory Role - EMD Serono; Pfizer
Research Funding - EMD Serono (Inst); Exelixis (Inst); Millennium (Inst)
 
David G. Pfister
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene
Research Funding - AstraZeneca; Bayer (Inst); Boehringer Ingelheim; Eisai (Inst); Exelixis; Genentech/Roche (Inst); Lilly (Inst); MedImmune; Merck; Novartis; Regeneron